Richard Daniell, EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 30,000 shares at $35.40 ($1.1M) on 2026-05-05, disclosed to the SEC on 2026-05-07.
Open-market sale of $1.1M TEVA by EVP, Europe Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |
| TEVA | SELL | 2025-03-07 | $2.3M | — | Filing → |